ABCA1

ABCA1 Full Name

ATP-binding cassette, sub-family A (ABC1), member 1

ABCA1 Introduction

ATP-binding cassette transporter A1 (ABCA1), frequently recognized in cardiovascular and metabolic research as the cholesterol efflux regulatory protein (CERP), is a ubiquitous and vital integral membrane protein. As a prominent member of the expansive ATP-binding cassette (ABC) superfamily, ABCA1 utilizes the energy derived from ATP hydrolysis to actively translocate substrates across cellular membranes. Structurally, it is characterized by two large transmembrane domains that form a transport channel and two highly conserved intracellular nucleotide-binding domains responsible for ATP engagement. While widely distributed, it is most heavily expressed in macrophages, hepatocytes, and enterocytes, functioning as the ultimate cellular gatekeeper for lipid homeostasis.

The primary and most critical physiological function of ABCA1 lies in its ability to mediate the active efflux of intracellular free cholesterol and phospholipids to extracellular lipid-poor apolipoproteins, predominantly Apolipoprotein A-I (ApoA-I). This dynamic molecular interaction constitutes the indispensable, rate-limiting first step in the biogenesis of nascent high-density lipoprotein (HDL) particles and the initiation of the reverse cholesterol transport (RCT) pathway. By actively pumping excess lipotoxic cholesterol out of peripheral cells—particularly lipid-laden macrophages within the arterial wall—and facilitating its transport back to the liver for biliary excretion, ABCA1 protects tissues from cholesterol toxicity and significantly dampens pro-inflammatory signaling pathways within the cellular microenvironment.

Figure 1. ATP-binding cassette transporter A1 (ABCA1) functions in different cell types and associated disease. (Source: Jacobo-Albavera L, et al. 2021)

Clinically, the functional integrity of ABCA1 is paramount to cardiovascular and metabolic health. Severe loss-of-function mutations in the ABCA1 gene are the direct molecular cause of Tangier disease, a rare autosomal recessive disorder characterized by a near-complete absence of circulating HDL, the massive accumulation of cholesteryl esters in tissue macrophages (forming "foam cells"), and remarkably enlarged, orange-colored tonsils. Even heterozygous genetic variants can lead to familial hypoalphalipoproteinemia, markedly accelerating the development of premature atherosclerosis and coronary artery disease. Beyond cardiovascular implications, emerging neurological research robustly links ABCA1 dysregulation to neurodegenerative conditions. In the central nervous system, ABCA1 strictly controls the lipidation of Apolipoprotein E (ApoE), a process that heavily influences the clearance and aggregation of amyloid-beta peptides, thereby impacting the progression and pathogenesis of Alzheimer's disease.

Alternate Names for ABCA1

ABCA1; ATP-binding cassette, sub-family A (ABC1), member 1; Abc1; ABC-1; ATP-binding cassette sub-family A member 1; ATP-binding cassette 1; ATP-binding cassette transporter 1;

• 1. Jacobo-Albavera L, et al. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. Int J Mol Sci. 2021 Feb 5;22(4):1593.
  2. Oram JF, et al. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol. 2000 Jun;11(3):253-60.